Abstract

Background: Detailed understanding on SARS-CoV-2 regional transmission networks within sub-Saharan Africa is key for guiding local public health interventions against the pandemic.

Methods: Here, we analysed 1,139 SARS-CoV-2 genomes from positive samples collected between March 2020 and February 2021 across six counties of Coastal Kenya (Mombasa, Kilifi, Taita Taveta, Kwale, Tana River and Lamu) to infer virus introductions and local transmission patterns during the first two waves of infections. Virus importations were inferred using ancestral state reconstruction and virus dispersal between counties were estimated using discrete phylogeographic analysis.

Results: During Wave 1, 23 distinct Pango lineages were detected across the six counties, while during Wave 2, 29 lineages were detected; nine of which occurred in both waves, and four seemed to be Kenya specific (B.1.530, B.1.549, B.1.596.1 and N.8). Most of the sequenced infections belonged to lineage B.1 (n=723, 63%) which predominated in both Wave 1 (73%, followed by lineages N.8 (6%) and B.1.1 (6%)) and Wave 2 (56%, followed by lineages B.1.549 (21%) and B.1.530 (5%). Over the study period, we estimated 280 SARS-CoV-2 virus importations into Coastal Kenya. Mombasa City, a vital tourist and commercial centre for the region, was a major route for virus imports, most of which occurred during Wave 1, when many COVID-19 government restrictions were still in force. In Wave 2, inter-county transmission predominated, resulting in the emergence of local transmission chains and diversity.

Conclusions: Our analysis supports moving COVID-19 control strategies in the region from a focus on international travel to strategies that will reduce local transmission.

Funding: This work was funded by The Wellcome (grant numbers; 220985, 203077/Z/16/Z, and 222574/Z/21/Z) and the National Institute for Health Research (NIHR), project references: 17/63/and 16/136/33 using UK aid from the UK Government to support global health research, The UK Foreign, Commonwealth and Development Office.

Data availability

1) Sequence data have been deposited in GISAID database under accession numbers provided in Supplement File 22) Source Data files have been provided for Figures 1-2 and 4-10.3) Source Code associated with the figures has been uploaded (Source Code File 1) and also been made available through Harvard Dataverse

The following data sets were generated
The following previously published data sets were used

Article and author information

Author details

  1. Charles N Agoti

    Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya
    For correspondence
    cnyaigoti@kemri-wellcome.org
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2160-567X
  2. Lynette Isabella Ochola-Oyier

    Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya
    Competing interests
    The authors declare that no competing interests exist.
  3. Simon Dellicour

    Department of Microbiology, Immunology and Transplantation, University of Leuven, Leuven, Belgium
    Competing interests
    The authors declare that no competing interests exist.
  4. Khadija Said Mohammed

    Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya
    Competing interests
    The authors declare that no competing interests exist.
  5. Arnold W Lambisia

    Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya
    Competing interests
    The authors declare that no competing interests exist.
  6. Zaydah R de Laurent

    Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya
    Competing interests
    The authors declare that no competing interests exist.
  7. John M Morobe

    Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-2398-6717
  8. Maureen W Mburu

    Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya
    Competing interests
    The authors declare that no competing interests exist.
  9. Donwilliams O Omuoyo

    Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-3900-5354
  10. Edidah M Ongera

    Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya
    Competing interests
    The authors declare that no competing interests exist.
  11. Leonard Ndwiga

    Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya
    Competing interests
    The authors declare that no competing interests exist.
  12. Eric Maitha

    Ministry of Health, Nairobi, Kenya
    Competing interests
    The authors declare that no competing interests exist.
  13. Benson Kitole

    Ministry of Health, Nairobi, Kenya
    Competing interests
    The authors declare that no competing interests exist.
  14. Thani Suleiman

    Ministry of Health, Nairobi, Kenya
    Competing interests
    The authors declare that no competing interests exist.
  15. Mohamed Mwakinangu

    Ministry of Health, Nairobi, Kenya
    Competing interests
    The authors declare that no competing interests exist.
  16. John K Nyambu

    Ministry of Health, Nairobi, Kenya
    Competing interests
    The authors declare that no competing interests exist.
  17. John Otieno

    Ministry of Health, Nairobi, Kenya
    Competing interests
    The authors declare that no competing interests exist.
  18. Barke Salim

    Ministry of Health, Nairobi, Kenya
    Competing interests
    The authors declare that no competing interests exist.
  19. Jennifer Musyoki

    Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya
    Competing interests
    The authors declare that no competing interests exist.
  20. Nickson Murunga

    Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya
    Competing interests
    The authors declare that no competing interests exist.
  21. Edward Otieno

    Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8014-7306
  22. John N Kiiru

    Ministry of Health, Nairobi, Kenya
    Competing interests
    The authors declare that no competing interests exist.
  23. Kadondi Kasera

    Ministry of Health, Nairobi, Kenya
    Competing interests
    The authors declare that no competing interests exist.
  24. Patrick Amoth

    Ministry of Health, Nairobi, Kenya
    Competing interests
    The authors declare that no competing interests exist.
  25. Mercy Mwangangi

    Ministry of Health, Nairobi, Kenya
    Competing interests
    The authors declare that no competing interests exist.
  26. Rashid Aman

    Ministry of Health, Nairobi, Kenya
    Competing interests
    The authors declare that no competing interests exist.
  27. Samson Kinyanjui

    Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya
    Competing interests
    The authors declare that no competing interests exist.
  28. George Warimwe

    Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya
    Competing interests
    The authors declare that no competing interests exist.
  29. My Phan

    Medical Research Centre, Uganda Virus Research Institute, Entebbe, Uganda
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-6905-8513
  30. Ambrose Agweyu

    Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya
    Competing interests
    The authors declare that no competing interests exist.
  31. Matthew Cotten

    Medical Research Centre, Uganda Virus Research Institute, Entebbe, Uganda
    Competing interests
    The authors declare that no competing interests exist.
  32. Edwine Barasa

    Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya
    Competing interests
    The authors declare that no competing interests exist.
  33. Benjamin Tsofa

    Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-1000-1771
  34. D James Nokes

    Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya
    Competing interests
    The authors declare that no competing interests exist.
  35. Philip Bejon

    Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya
    Competing interests
    The authors declare that no competing interests exist.
  36. George Githinji

    Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9640-7371

Funding

National Institute for Health Research (17/63/82)

  • D James Nokes

National Institute for Health Research (16/136/33)

  • Charles N Agoti
  • Samson Kinyanjui
  • George Warimwe
  • D James Nokes
  • George Githinji

Wellcome Trust (220985)

  • D James Nokes
  • George Githinji

Wellcome Trust (203077/Z/16/Z)

  • Edwine Barasa
  • Benjamin Tsofa
  • Philip Bejon

Wellcome Trust (220977/Z/20/Z)

  • My Phan
  • Matthew Cotten

Medical Research Council (NC_PC_19060)

  • My Phan
  • Matthew Cotten

H2020 European Research Council (n{degree sign}874850)

  • Simon Dellicour

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Human subjects: Samples analysed here were collected under the Ministry of Health protocols as part of the national COVID-19 public health response. The whole genome sequencing study protocol was reviewed and approved by the Scientific and Ethics Review Committee (SERU) at Kenya Medical Research Institute (KEMRI), Nairobi, Kenya (SERU protocol #4035). Individual patient consent was not required by the committee for the use of these samples for studies of genomic epidemiology to inform public health response.

Copyright

© 2022, Agoti et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,428
    views
  • 396
    downloads
  • 9
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Charles N Agoti
  2. Lynette Isabella Ochola-Oyier
  3. Simon Dellicour
  4. Khadija Said Mohammed
  5. Arnold W Lambisia
  6. Zaydah R de Laurent
  7. John M Morobe
  8. Maureen W Mburu
  9. Donwilliams O Omuoyo
  10. Edidah M Ongera
  11. Leonard Ndwiga
  12. Eric Maitha
  13. Benson Kitole
  14. Thani Suleiman
  15. Mohamed Mwakinangu
  16. John K Nyambu
  17. John Otieno
  18. Barke Salim
  19. Jennifer Musyoki
  20. Nickson Murunga
  21. Edward Otieno
  22. John N Kiiru
  23. Kadondi Kasera
  24. Patrick Amoth
  25. Mercy Mwangangi
  26. Rashid Aman
  27. Samson Kinyanjui
  28. George Warimwe
  29. My Phan
  30. Ambrose Agweyu
  31. Matthew Cotten
  32. Edwine Barasa
  33. Benjamin Tsofa
  34. D James Nokes
  35. Philip Bejon
  36. George Githinji
(2022)
Transmission networks of SARS-CoV-2 in Coastal Kenya during the first two waves: a retrospective genomic study
eLife 11:e71703.
https://doi.org/10.7554/eLife.71703

Share this article

https://doi.org/10.7554/eLife.71703

Further reading

    1. Epidemiology and Global Health
    2. Genetics and Genomics
    Tianyu Zhao, Hui Li ... Li Chen
    Research Article

    Alzheimer’s disease (AD) is a complex degenerative disease of the central nervous system, and elucidating its pathogenesis remains challenging. In this study, we used the inverse-variance weighted (IVW) model as the major analysis method to perform hypothesis-free Mendelian randomization (MR) analysis on the data from MRC IEU OpenGWAS (18,097 exposure traits and 16 AD outcome traits), and conducted sensitivity analysis with six models, to assess the robustness of the IVW results, to identify various classes of risk or protective factors for AD, early-onset AD, and late-onset AD. We generated 400,274 data entries in total, among which the major analysis method of the IVW model consists of 73,129 records with 4840 exposure traits, which fall into 10 categories: Disease, Medical laboratory science, Imaging, Anthropometric, Treatment, Molecular trait, Gut microbiota, Past history, Family history, and Lifestyle trait. More importantly, a freely accessed online platform called MRAD (https://gwasmrad.com/mrad/) has been developed using the Shiny package with MR analysis results. Additionally, novel potential AD therapeutic targets (CD33, TBCA, VPS29, GNAI3, PSME1) are identified, among which CD33 was positively associated with the main outcome traits of AD, as well as with both EOAD and LOAD. TBCA and VPS29 were negatively associated with the main outcome traits of AD, as well as with both EOAD and LOAD. GNAI3 and PSME1 were negatively associated with the main outcome traits of AD, as well as with LOAD, but had no significant causal association with EOAD. The findings of our research advance our understanding of the etiology of AD.

    1. Epidemiology and Global Health
    Xiaoning Wang, Jinxiang Zhao ... Dong Liu
    Research Article

    Artificially sweetened beverages containing noncaloric monosaccharides were suggested as healthier alternatives to sugar-sweetened beverages. Nevertheless, the potential detrimental effects of these noncaloric monosaccharides on blood vessel function remain inadequately understood. We have established a zebrafish model that exhibits significant excessive angiogenesis induced by high glucose, resembling the hyperangiogenic characteristics observed in proliferative diabetic retinopathy (PDR). Utilizing this model, we observed that glucose and noncaloric monosaccharides could induce excessive formation of blood vessels, especially intersegmental vessels (ISVs). The excessively branched vessels were observed to be formed by ectopic activation of quiescent endothelial cells (ECs) into tip cells. Single-cell transcriptomic sequencing analysis of the ECs in the embryos exposed to high glucose revealed an augmented ratio of capillary ECs, proliferating ECs, and a series of upregulated proangiogenic genes. Further analysis and experiments validated that reduced foxo1a mediated the excessive angiogenesis induced by monosaccharides via upregulating the expression of marcksl1a. This study has provided new evidence showing the negative effects of noncaloric monosaccharides on the vascular system and the underlying mechanisms.